5 results match your criteria: "University Cruces Hospital[Affiliation]"
J Inherit Metab Dis
March 2021
Pediatric Neurology Research Group, Hospital Vall d'Hebrón, Barcelona, Spain.
The neurological phenotype of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) and short-chain enoyl-CoA hydratase (SCEH) defects is expanding and natural history studies are necessary to improve clinical management. From 42 patients with Leigh syndrome studied by massive parallel sequencing, we identified five patients with SCEH and HIBCH deficiency. Fourteen additional patients were recruited through collaborations with other centres.
View Article and Find Full Text PDFEur J Pediatr
June 2019
Group of Metabolism, Biocruces Bizkaia Health Research Institute, CIBER de Enfermedades Raras (CIBERER), Plaza de Cruces 12, 48903, Barakaldo, Spain.
JAMA Neurol
June 2018
Osatek Magnetic Resonance Imaging Unit, Galdakao Hospital, Galdakao, Spain.
Foot Ankle Spec
April 2018
University Clinic of Navarra, Orthopedic Surgery and Traumatology Department, Pamplona, Navarra, Spain (JP-O, MAO-G, CVT).
Unlabelled: Fractures at the proximal metaphyso-diaphyseal junction of the fifth metatarsal are associated with high rates of delayed union. When these fractures are the result of repeated stress in patients with equinovarus hindfoot, which in turn is caused by neurological disorders, delayed union is the rule. Therefore, in neurological patients with stress fractures, optimal treatment would be to achieve a plantigrade foot enabling them to relieve the fifth metatarsal overload, which prevents the consolidation.
View Article and Find Full Text PDFJ Inherit Metab Dis
August 2001
Paediatrics Department, University Cruces Hospital, Cruces-Baracaldo, Spain.
Nutritional management of very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is based on the avoidance of fasting and substitution of medium-chain triglycerides for long- and very long-chain triglycerides. We report two cases of this disease, which developed omega-6 essential fatty acid deficiency after three and five months from the beginning of nutritional therapy (SHS product: Monogen). This alteration could be especially dangerous in these patients owing to their possible susceptibility to the development of pigmentary retinopathy.
View Article and Find Full Text PDF